Marshall Fordyce
2022
In 2022, Marshall Fordyce earned a total compensation of $4.1M as President and Chief Executive Officer at Vera Therapeutics, a 176% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $277,550 |
|---|---|
| Option Awards | $2,463,989 |
| Salary | $551,340 |
| Stock Awards | $813,750 |
| Total | $4,106,629 |
Fordyce received $2.5M in option awards, accounting for 60% of the total pay in 2022.
Fordyce also received $277.6K in non-equity incentive plan, $551.3K in salary and $813.8K in stock awards.
Rankings
In 2022, Marshall Fordyce's compensation ranked 839th out of 5,760 executives tracked by ExecPay. In other words, Fordyce earned more than 85.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 839 out of 5,760 | 85th |
Division Manufacturing | 381 out of 3,136 | 88th |
Major group Chemicals And Allied Products | 131 out of 1,422 | 91st |
Industry group Drugs | 118 out of 1,323 | 91st |
Industry Pharmaceutical Preparations | 89 out of 969 | 91st |
Source: SEC filing on March 30, 2023.
Fordyce's colleagues
We found two more compensation records of executives who worked with Marshall Fordyce at Vera Therapeutics in 2022.